MEGAN YEAGER: Open Payments
NPI 1518614312 · LEBANON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,361 in 90 payments from 13 companies in 2025. Trend: 2023 $141 · 2024 $1,412 · 2025 $2,361
Food & beverage: $2,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $534 |
| Madrigal Pharmaceuticals | 14 | $518 |
| GENZYME CORPORATION | 14 | $419 |
| Janssen Biotech, Inc. | 10 | $266 |
| Ardelyx, Inc. | 3 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, RINVOQ, XIFAXAN, MAVYRET, SKYRIZI.
Industry payments across PA — which companies pay providers there.
